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1. Introduction
1.1 Nucleoside and Nucleotide Synthesis and Degra-
dation Pathways
Nucleosides and nucleotides are synthesized by two major routes: de novo pathways and
salvage pathways. De novo pathways can be described as a scavenge operation in which
carbon and nitrogen atoms are taken from available metabolites and used to create purine
and pyrimidine bases. Typical source metabolites include amino acids, 𝑁 10-formyltetrahy-
drofolate, carbamoyl phosphate and carbon dioxide. Salvage pathways make nucleotides
directly from 5′-phosphoribosyl-1-pyrophosphate (PRPP, Figure 1.1a) and purines/pyrim-
idines produced during nucleotide degradation (Nelson and Cox 2012).
Purine synthesis starts by amination of PPRP at position 1 by the action of glutamine-
PRPP amidotransferase. A glycyl and a formyl moiety are added: all members of the
five-membered ring are present. An amine group is then transferred from glutamine as
a foundation for the six-membered ring. It is only after this latest modification that the
five-membered ring closes. The remaining three atoms of the six-membered ring come
from carbon dioxide, aspartate and 𝑁 10-formyltetrahydrofolate (Figure 1.1b). Inosine 5′-
monophosphate (IMP) is formedwhen the six-membered ring closes. Oxidation and transa-
midation at position 2 yield guanosine 5′-monophosphate (GMP, Figure 1.1c), while transam-
ination at position 8 yields adenosine 5′-monophosphate (AMP, Figure 1.1d). All three prod-
ucts (AMP, GMP and IMP) inhibit glutamine-PRPP amidotransferase (the first enzyme in
this pathway), thus self-regulating their concentration in cells (Kappock et al. 2000; Nelson
and Cox 2012).
Pyrimidine synthesis starts with aspartate transcarbamoylase which creates N -carba-
moylaspartate from aspartate and carbamoyl phosphate (H2NCOOPO3
2– ; Figure 1.2a). Cy-
clization results in formation of a six-membered ring which is subsequently reduced. The
reduction product, orotate (Figure 1.2b), reacts with PRPP to finally create a nucleotide.
Decarboxilation of said nucleotide yields uracyl 5′-monophosphate (Figure 1.2c). Uracyl
5′-monophosphate is phosphorylated twice, yielding uracyl 5′-triphosphate which is used
either as a precursor for RNA synthesis or transamidated into cytidine 5′-triphosphate (Fig-
1
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(a) 5′-phosphoribo-
syl-1-pyrophosphate
(PRPP).
(b) Metabolites from
which parts of the purine
ring are made.
(c) Guanosine. (d) Adenosine.
Figure 1.1. Important aspects of the purine biosyntethic pathway (Nelson and Cox 2012).
ure 1.2d). Cytidine 5′-triphosphate inhibits aspartate transcabamoylase, and therefore the
whole pathway in a similar manner to purine biosynthesis regulation (Canellakis 1957;
Nelson and Cox 2012).
DNA synthesis requires 2′-deoxyribonucleotides and thymidine 5′-triphosphate. 2′-de-
oxyribonucleotides are made from ribonucleotide 5′-diphosphates or ribonucleotide 5′-tri-
phosphates. Ribonucleotide reductase catalyses the oxygen removal via a radical reduction
involving cysteine side chains. This enzyme is strictly regulated via two groups of regula-
tory sites: the primary sites, influenced by dATP/ATP ratio so as not to overproduce dATP,
and the specific dNTP-binding sites whose role is to keep the deoxyribonucleotide (dATP/d-
CTP/dGTP/TTP) ratios balanced (Cotruvo and Stubbe 2011). Thymidine 5′-monophosphate
(Figure 1.2c) is formed by a transfer of amethylene group to deoxyuracyl 5′-monophosphate
and an immediate reduction. Both processes are catalyzed by thymidilate synthase utilizing
𝑁 5,𝑁 10-methylenetetrahydrofolate as a cofactor (Nelson and Cox 2012).
Nucleoside degradation begins by a cleavage of the glycoside bond between nucleobase
and ribosyl moieties. Subsequent reactions ultimately yield excretion products which vary
depending on the organism in question. Purines are degraded to uric acid in humans and
mice; to ammonia in fish. Pyrimidines are only partially degraded to ammonia; the remain-
ing part of pyrimidine moiety is reused in metabolic reactions (Nelson and Cox 2012).
Not all nucleosides undergo full degradation. Some nucleoside degradation products
can be reused to make new nucleosides. This process is called nucleoside salvage. Hy-
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(a) Aspartate (black) and
carbamoyl phosphate
(red).
(b) Orotate. Atoms orig-
inating from carbamoyl
phosphate are marked
red.
(c) Uridine (R1=H,
R2=OH) and thymidine
(R1=CH3, R2=H).
(d) Cytidine.
Figure 1.2. Important aspects of the pyrimidine biosyntethic pathway (Nelson and Cox
2012).
poxantine and guanine are (re)attached to a ribosyl moiety by the action of hypoxantine-
guanosine phosphoriboysltransferase (HGPRT). Adenosine is salvaged in a similar manner
from adenine and 5′-phosphorybosyl 1-pyrophosphate by adenine phosphoriboysltrans-
ferase (APRT). Uridine phosphorylase and thymidine phosphorylase catalyse reversible
phosphorolysis of pyrimidine nucleotides. Salvage is preferred under physiological condi-
tions. Cytidine 5′-monophosphate is obtained from uridine 5′-monophosphate via a trans-
amidation reaction by cytidine deaminase (Krenitsky et al. 1964; Nelson and Cox 2012).
1.2 Purine Nucleoside Phosphorylase
Another important enzyme in the nucleoside degradation and salvage pathways is called
the purine nucleoside phosphorylase (PNP; purine nucleoside:ortophosphate ribosyltrans-
ferase, EC 2.4.2.1). It catalyses the reversible phosphorolysis of purine nucleotides (Figure
1.3; Ealick et al. 1990).
Like other major components of the nucleoside metabolism, it is found in all known
organisms. Purine nucleoside phosphorylase can take part in both nucleoside salvage and
degradation, like pyrimidine nucleoside phosphorylase mentioned earlier. Salvage is ther-
modynamically favoured (𝐾 = 500), but degradation is preferred under physiological con-
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Figure 1.3. Summary phosphorolysis reaction catalyzed by the PNP enzyme (Ealick et al.
1990).
ditions (Erion et al. 1997a).
Purine nucleoside phosphorylases probably bind hydrogenphosphate ions since most
anions present in bulk solution at phisiological pH (≈7.4) are hydrogenphosphate and di-
hydrogenphosphate at a ratio of approximately 3:2. However, phosphate ions are typically
mentioned in crystallographic studies since hydrogen atom positions cannot be accurately
determined by that method. In fact, both terms (hydrogenphosphate and phosphate) are
often used interchangeably. Throughout this Thesis, the term hydrogenphosphate ions are
used in discussion involving computational studies or proposed PNP catalytic mechanisms,
while the term phosphate ions is used when describing crystal structures of PNP enzymes.
1.2.1 Human PNP
Human (Homo sapiens) PNP (HsPNP) enzyme is encoded by the PNP gene located in the
pericentric region on the longer arm of the 14th chromosome. The whole gene contains
8628 base pairs, 867 of which encode PNP’s 289 amino acids (UniProtKB Entry: P00491).
All known PNPs are homooligomeric enzymes. Their active sites are located on contact
surfaces between monomers. One monomer forms most of the active site, while its neigh-
bour donates several residues important for catalysis and substrate specificity. HsPNP is
trimeric, with a C3 molecular axis. Monomers are arranged in a head-to-tail manner. It
tends to crystallize in trigonal space groups (Ealick et al. 1990; Erion et al. 1997a).
Overall the HsPNP enzyme structure includes two β-sheets (one eight-stranded and
the other five-stranded) forming a distorted β-barrell. Secondary structure β-sheets are
surrounded by seven α-helices. Surprisingly, no Rosmann fold motif (𝛼𝛽𝛼𝛽… ) is observed.
Several loops connect α-helices and β-sheets. The whole enzyme is about 6 nm thick and 7
nm in diameter (Figure 1.4; Ealick et al. 1990; Erion et al. 1997a).
Human and bovine PNPs are more selective about their substrate than their Escherichia
coli counterpart. Their affinity for 6-aminopurine nucleosides (adenosine and its deriva-
tives) is nearly non-existent, whereas 6-oxopurine nucleosides (guanosine, inosine and the
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Figure 1.4. Structure of human purine nucleoside phosphorylase. Red: α-helices, yellow:
β-sheets, green: loops, blue: ligand. PDB ID: 3BGS. (Rinaldo-Matthis et al. 2008)
like) are normally degraded. This specificity arises from amino acids Glu201 and Asn243 in
HsPNP enzyme’s active site. Glu201 can accepts a hydrogen bond from the purine N1 atom.
6-oxopurines have a hydrogen bond donor at that position (N1—H), while 6-aminopurines
do not. Asn243 amide nitrogen atom donates hydrogen bonds to both O6 and N7 of the
purine ring of 6-oxopurines, while having trouble accepting a hydrogen bond from N6 of
6-aminopurines (Figure 1.5; Erion et al. 1997b; Mao et al. 1997).
Active site flexibility in terms of accommodation of diverse substrates was probed via
site-directed mutagenesis. Asn243Asp mutants showed significantly increased affinity for
6-aminopurines: it was almost as strong as wild type affinity towards 6-oxopurines.
Glu201Gln mutants, however, did not significantly impact specificity, but dramatically re-
duced catalytic rates for both 6-aminopurines and 6-oxopurines. On the other hand, the
double mutant (Glu201Gln::Asn243Asp) prefers adenosine and retains high catalytic effi-
ciency, showing potential for catalytic applications in organic synthesis of purine nucleo-
side analogues (Stoeckler et al. 1997).
HsPNP is selective of the nucleoside’s sugar moiety as well. Ribose interacts primarily
with Phe159 from the neighbouring subunit via dispersive interactions and with His257
which forms hydrogen bonds with the 5′-hydroxyl group. Substitution of ribosyl moiety
for other pentosyls (xylosyl, lyxosyl or arabinosyl) significantly reduces catalytic activity
of the HsPNP enzyme (Erion et al. 1997b).
The postulated catalytic mechanism for the HsPNP enzyme is an ordered bi-bi mech-
anism: nucleoside enters the active site, followed by phosphate binding; after they react,
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Figure 1.5. Proposed catalytic mechanism of human purine nucleoside phosphorylase.
Phenylalanine 159 belongs to the neighbouring subunit (Erion et al. 1997b).
1-phosphoribose leaves the site followed by the purine base. This proposition is consistent
with both the nucleoside active site being deeper inside the HsPNP enzyme structure and
reaction reversibility (Erion et al. 1997b).
The putative mechanism (Figure 1.5) starts by deprotonation of dihydrogenphosphate
by His86 in a manner reminiscent of catalytic triads. The purine nucleoside is bound in an
anti conformation with the 𝜒 angle (O4′—C1′—N9—C4) about 145° (the conformations are
defined as: syn for −90° ≥ 𝜒 ≥ 90° and anti for −180° ≥ 𝜒 ≥ −90° and 90° ≥ 𝜒 ≥ 180°; Lu 2017).
This conformation facilitates glycoside bond cleavage induced by protonation of N7 nitro-
gen (via Asn243) and electrostatic interactions with hydrogenphosphate in the vicinity of
the glycoside bond. Carbenium cation forms as the glycoside bond breaks, hydrogenphos-
phate’s negative charge stabilises it. A covalent bond is made between hydrogenphosphate
and the carbenium cation, yielding 1-phoshporybose (Erion et al. 1997b).
1.2.2 Escherichia coli PNP
The Escherichia coli PNP (EcPNP) enzyme is encoded by the deoD gene. Other genes on the
deo operon are involved in deoxyribonucleotide and ribonucleotide catabolysm. There is
Computational investigation of Helicobacter pylori purine nucleoside phosphorylase 7
also the deoR gene encoding for the operon’s repressor DeoR.The EcPNP enzymemonomer
is shorter than itsHsPNP enzyme counterpart, containing only 235 amino acids (UniProtKB
Entry: P0ABP8). It spontaneously forms homohexamers.
EcPNP hexamer enzyme is about 10 nm across and 6 nm thick (Figure 1.6). It has a D3
molecular symmetry. A catalytic site is formed by several amino acids from one monomer
and two, His4 and Arg43, from its neighbour (Mao et al. 1997). Monomers are not connected
in a head-to-tail manner as in HsPNP. Instead they form dimers with two active sites; each
monomer donates the two important amino acids to its partner. A hexamer is assembled
as a trimer of dimers. Oligomerization of dimers stabilizes the bindings site and is required
for proper protein function (Bertoša et al. 2014).
There is little primary sequence similarity between the HsPNP enzyme and the EcPNP
enzyme (Figure 1.7). Coincidentally, both have Phe159 involved in substrate binding. Phe159
of the HsPNP enzyme, as mentioned earlier, interacts with the nucleoside ribosyl moiety,
whereas Phe159 of the EcPNP enzyme interacts with the purine base via π-interactions
(Mao et al. 1997). Homology between the two enzymes is revealed largely by secondary
structure topology. Both enzymes, as well as E. coli uridine phosphorylase (a pyridine nu-
cleoside phosphorylase), share the same distorted β-barrel core surrounded by several α-
helices. There is one more β-strand and one fewer α-helix in the EcPNP enzyme compared
to the HsPNP enzyme (Mao et al. 1997).
The EcPNP enzyme is not as specific about the nucleoside 6-substituent as the HsPNP
Figure 1.6. Structure of Escherichia coli purine nucleoside phosphorylase. Red: α-helices,
yellow: β-sheets, green: loops, blue: ligand (formycin A). PDB ID: 3BGS (Štefanić et al.
2012).
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Figure 1.7. Multiple sequence alignment of human (HsPNP), Escherichia coli (EcPNP), He-
licobacter pylori (HpPNP) purine nucleoside phosphorylase and uridylate phosphorylase
(UP), a pyrimidine nucleoside phosphorylase (Mao et al. 1997). The alignment was ren-
dered using ESPPript (Robert and Gouet 2014).
enzyme is. This is mainly due to Asp204 being homologous to Asn243 from the HsPNP
enzyme. As previously mentioned, Asn243Asp mutants of the HsPNP enzyme are also not
very selective about the 6-substituent (Stoeckler et al. 1997). Another major difference is
in ribosyl moiety coordination: Glu181 accepts hydrogen bonds from 2′ and 3′-hydroxyl
groups, while His4 from the neighbouring subunit accepts the hydrogen bond from the
5′-hydroxyl group (Mao et al. 1997).
The phosphate anion is coordinated by glycine 20, arginines 24, 43 (from the adjacent
monomer), 87 and serine 90 (Koellner et al. 1998). There is another putative phosphate active
site closer to the protein surface (Štefanić et al. 2012). It was hypothesized that phosphate
ions induce conformational changes to the H8 (α7) helix. Active site conformations with a
contiguous H8 helix are designated as open. If the H8 helix breaks, forming a short γ-loop at
residues 218–220, catalytically important Arg217 moves closer to the nucleoside active site;
this conformation is designated as closed. Negative cooperativity between active sites, as
discovered by kinetic measurements, suggests a putative allosteric regulation mechanism.
Its identification has so far been elusive (Koellner et al. 1998).
Proposed EcPNP’s catalytic mechanism (Figure 1.8) is similar to HsPNP’s, however the
substrate binding order appears to follow a random bi-bi mechanism. Arg24 interacts with
Arg217 upon the closing of the active site. This enables proton transfer from Arg217 to
Asp204 which subsequently protonates the purine N7 atom. Thus the glycoside bond is
Computational investigation of Helicobacter pylori purine nucleoside phosphorylase 9
Figure 1.8. Proposed catalytic mechanism of Escherichia coli purine nucleoside phosphory-
lase. Histidine 4 belongs to the neighbouring subunit. Helix H8 breaks during the reaction
(Koellner et al. 2002).
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weakened and prepared for a nucleophilic attack by the phosphate. The phosphate is sta-
bilized and positioned for the attack by arginines, including Arg24. Stabilization of Arg217
by Arg24 is the putative mechanism by which hydrogenphosphate (after binding to Asp24)
affects the conformation change from an open to a closed active site. It is proposed that
the phosphate’s negative charge also electrostatically stabilizes the protonated substrate
through the reaction (Koellner et al. 2002; Štefanić et al. 2012).
1.2.3 Medical uses and implications
The EcPNP enzyme is long regarded as a potential drug target due to the differences between
it and the HsPNP enzyme. In particular, the difference in selectivity towards adenosine
and similar 6-aminopurine nucleosides sets up the stage for new drug discovery research
projects. Such drugs would be reasonably safe for human cells since the HsPNP enzyme
and other trimeric PNPs are virtually unable to bind and process them. However, there
may be problems with important bacteria forming intestinal microflora which could also be
adversely affected by such drugs as they contain enzymes highly homologous to the EcPNP
enzyme (Bennett et al. 2003). The HsPNP enzyme could also be a viable drug target as it is
more important for some cells in the human body. E.g. T cells of the immune system are
more susceptible to lack of HsPNP enzyme activity, making the HsPNP enzyme a potential
drug target for T cell malignancies (Bennett et al. 1993; Ealick et al. 1990).
Prodrug designer gene therapy for tumours is of late an increasingly popular field of
research. The basic idea of prodrug therapy is to utilize the difference in target (e.g. tu-
mour, pathogenic bacteria etc.) and normal cell metabolism. Prodrugs are not metabolised
by normal cells, while target cells convert them into active drugs by covalent modification.
Designer gene therapy works by introducing the enzyme catalysing the covalent modifica-
tion into target cells (Rautio et al. 2008).
EcPNP / 6-methylpurine nucleoside is a promising prodrug designer gene therapeuti-
cal system for solid tumour treatment (Figure 1.9). It involves transfecting tumour cells
specifically with the the EcPNP gene and administering 6-methylpurine nucleoside to pa-
tients. Once the glycoside bond is cleaved inside a tumour cell, highly toxic 6-methylpurine
destroys it. In vivo experiments on tumour grafts were quite successful, especially owing
to 6-methylpurine’s high bystander effect (i.e. the ability to cross plasma membranes of
neighbouring cells and destroy them as well; Sorscher et al. 1994).
Amajor drawback of using 6-methylpurine nucleoside is that intestinal microflora PNPs
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Figure 1.9. Application of the EcPNP / 6-methylpurine nucleoside prodrug system. Normal
human cells do not metabolise the prodrug. In tumour cells transfected with the EcPNP
gene the glycoside bond (green) breaks, releasing toxic 6-methylpurine (red). Intestinal
microflora have enzymes similar to the EcPNP enzyme, making them also susceptible to
the treatment (Rautio et al. 2008).
are susceptible to it, thus seriously limiting dosage of 6-methylpurine nucleoside. This was
largely resolved by utilizing site-directed mutagenesis to create the EcPNP enzyme M64V
mutants which can accommodate 6-methylpurine 6′-deoxytaloside as well as the usual 6-
methylpurine riboside (6-methylpurine nucleoside). The effectiveness of this treatment has
been demonstrated in vivo (Bennett et al. 2003).
1.3 Computational Methods
It is in principle possible to predict any quantity which can be measured. In practice, how-
ever, predicting some properties is easier than predicting others. Even when properties are
simple to predict, one might require a substantial amount of computational time to obtain
an accurate result (Cramer 2004).
Dynamic properties of a particle system can in principle be obtained from its wave func-
tion Ψ. The wave function is the solution of Erwin Schrödinger’s equation (Schrödinger
1926). One must resort to the approximation given by Max Born and Robert Oppenheimer
to solve Schrödinger’s equation for a molecular system (Born and Oppenheimer 1927).
Born-Oppenheimer approximation introduces the concept of a potential energy surface
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which correlates nuclear coordinates (molecular geometry) and the potential energy of a
conformer.
Once there is a way to calculate the potential energy for a given molecular geometry, a
potential energy minimum can be found using a method known as energy minimisation or
geometry optimisation. It is also possible to determine how the potential energy surface of
a molecule depends on a few select coordinates.
Energy calculations based on quantum theory are computationally intensive even for
systems consisting of a few hundred atoms. Approximations to the quantum approach (so
called semi-empirical calculations) can be introduced for somewhat larger systems consist-
ing of a few thousand atoms. Systems of biological interest like proteins, polynucleotides,
and complexes thereof, are still inaccessible to such energy calculations due to prohibitively
large time costs. Force filed basedmethods are often applied for such systems (Cramer 2004;
Leach 2001).
1.3.1 Force Field Based Methods
Energy calculations for macromolecular systems are based on a different approach. Molec-
ular energy can be approximated as a sum of different contributions: covalent bond, va-
lence and torsion angle (contributing to molecular strain), electrostatic, dispersive, and
other terms. Each of these contributions can be modelled. One needs to take into account
both accuracy and computational demands when choosing between different models, par-
ticularly for a macromolecular system. Additionally, an adequate set of parameters needs
to be devised for each model. The model capable of estimating molecular energy based
on molecular geometry along with appropriate parameters is called the force field (Cramer
2004).
The Functional Form
The potential energy of a molecule can be estimated using a functional form like this one:
𝑉 = ∑
(AB)
𝑘(AB)(𝑟(AB) − 𝑟e(AB))
2 + ∑
(ABC)
𝑘(ABC)(𝜃(ABC) − 𝜃𝑒(ABC))
2+
∑
𝑛,(ABCD)
𝑣𝑛(ABCD)
2
[1 + cos(𝑛𝜑(ABCD) − 𝜑e(ABCD))] +∑
𝑖
∑
𝑗>𝑖
𝑞𝑖𝑞𝑗
𝜖𝑟𝑖𝑗
+∑
𝑖
∑
𝑗>𝑖
[
𝐴𝑖𝑗
𝑟12𝑖𝑗
−
𝐵𝑖𝑗
𝑟6𝑖𝑗 ]
. (1.1)
This potential functional form is the basis for all Amber force fields (Cornell et al. 1995;
Computational investigation of Helicobacter pylori purine nucleoside phosphorylase 13
Maier et al. 2015; Ponder and Case 2003; Wang et al. 2000, 2004).
The first sum in the functional form goes over all covalently bound atom pairs (AB).
It is used to calculate contributions of covalent bonds 𝑉b to the total potential energy 𝑉.
The contribution of an individual covalent bond between atoms A and B is modelled as a
harmonic potential:
𝑉b(AB) = 𝑘(AB)(𝑟(AB) − 𝑟e(AB))
2. (1.2)
The distance 𝑟 is the A—B bond length defined as the Euclidean distance between atomic
nuclei:
𝑟(AB)(qA,qB) = ||qA − qB|| = √
(𝑞A𝑥 − 𝑞B𝑥)2 + (𝑞A𝑦 − 𝑞B𝑦)2 + (𝑞A𝑧 − 𝑞B𝑧)2. (1.3)
Experimental spectroscopy and theoretical statistical thermodynamics validate this as a
valid approximation of covalent bond potentials at room temperature. A similar case can be
made for valence angles between covalently bound atoms A—B—C.Thus, they are modelled
similarly:
𝑉a(ABC) = 𝑘(ABC)(𝜃(ABC) − 𝜃𝑒(ABC))
2. (1.4)
The model used to account for contributions of dihedral (𝜑(ABCD)) angles is somewhat
more involved:
𝑉dih(ABCD) = ∑
𝑛
𝑣𝑛(ABCD)
2
[1 + cos(𝑛𝜑(ABCD) − 𝜑e(ABCD))]. (1.5)
It is based on a Fourier series because the torsion is periodic with a period of 2𝜋 (i.e. the
conformation after a 2𝜋 rotation around the B—C bond is the same as the starting confor-
mation). The electrostatic model is a typical Coulomb-type potential:
𝑉e,𝑖𝑗 =
𝑞𝑖𝑞𝑗
𝜖𝑟𝑖𝑗
. (1.6)
Electrostatic contributions are calculated for all atom pairs except those separated with one
or two covalent bonds, in contrast to the covalent bond, valence and dihedral angle models
which presume the existence of atoms which are covalently bound in the manner A—B,
A—B—C and A—B—C—D, respectively. Electrostatic contributions of atoms one and two
covalent bonds apart are implicitly included by fitting the bond and valence angle models
to experimental data. The dihedral model cannot fully account for interactions between
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most distant (A and D) atoms, so a partial electrostatic contribution is calculated for them.
The final model is a Lennard-Jones potential describing dispersive interactions of atoms
at a distance 𝑟𝑖𝑗:
𝑉dis,𝑖𝑗 = [
𝐴𝑖𝑗
𝑟12𝑖𝑗
−
𝐵𝑖𝑗
𝑟6𝑖𝑗
.
]
(1.7)
The 𝑟−6𝑖𝑗 -term, representing inter-atomic attraction, is theoretically justified. The 𝑟
−12
𝑖𝑗 -term
is meant to represent inter-atomic repulsion. Calculating exponential functions is compu-
tationally more demanding than multiplying two numbers (𝑟−12𝑖𝑗 = 𝑟
−6
𝑖𝑗 ⋅ 𝑟
−6
𝑖𝑗 ). While time
saved by evaluating one multiplication instead of an exponential function may be small,
dispersive interactions are calculated for atoms at least four covalent bonds apart; the cu-
mulative effect of all the small time savings is significant for a macromolecular simulation
(Cramer 2004).
Parametrisation
Several parameters are required to evaluate the equation 1.1. Parameters 𝑘(AB) (the force
constant) and 𝑟e(AB) (the equilibrium distance) are necessary for describing covalent bonds.
Similarly, 𝑘(ABC) and 𝜃e(ABC) are used to describe valence angles, while 𝑣𝑛(ABCD) and 𝜑e(ABCD)
describe dihedral angles. It is difficult to fully describe the interaction between atoms A
and D using just these parameters and the third sum in 1.1. All of these parameters can
be obtained by fitting their respective models to experimental data obtained mostly from
crystallography and spectroscopy.
The parameter 𝜖 is used to describe electrostatic interactions. 𝜖 depends mainly on the
choice of solvent. Biologically interesting solvents are water (for which 𝜖 = 78.5) and cy-
tosol (𝜖 ≈ 81). The parameter 𝜖 also depends on the number of covalent bonds between two
atoms: 𝜖 = 81 (or whichever value is appropriate) for nearly all atoms, but 𝜖 = ∞ if atoms
are one or two bonds apart (electrostatic interactions of those atoms are well described by
covalent bond and valence angle terms, as mentioned earlier). For atoms that are three co-
valent bonds apart 𝜖 = 162 (twice as large as for atoms that are more than three covalent
bonds apart). This doubling of 𝜖 halves the electrostatic contribution to the total energy.
Thus the slightly incorrect dihedral angle contribution to total energy is compensated by
this, slightly reduced, electrostatic contribution.
The parameters 𝐴𝑖𝑗 and 𝐵𝑖𝑗 are used to describe dispersive interactions. These interac-
tions are important for investigating conformational changes in macromolecular systems,
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and yet they are the hardest to parametrise. Data for parametrisation is obtained from ther-
modynamical or similar experiments when available; when unavailable, high-level quan-
tum chemistry calculations are employed as a substitute.
Force field parametrisation is complicated, and a set of general parameters which would
satisfactorily cover all of chemistry is far from reality. Parameters are usually fitted using
data for a small number of compounds, typically organic, and their validity for significantly
different compounds is dubious. Several force fields have been parametrised for use in
macromolecular simulations, most notably AMBER, OPLS and CHARM force fields (Cramer
2004).
1.3.2 Preparation of Macromolecular Structures for Molecular
DockingCalculations andMolecularDynamics Simulations
Computational methods rely on structural data as a starting point of calculations. Struc-
tures can be generated using models (e.g. homology modelling) or obtained experimentally
from X-ray crystallography, spectroscopy and microscopy (in case of macromolecular com-
plexes). Experimentally obtained macromolecular structures usually lack hydrogen atoms,
so they have to be added in silico before any calculations are performed. It is important to
properly model the macromolecular hydrogen bond network when adding hydrogen atoms
to polar amino acid residues.
In some modifications of the force field, not all hydrogen atoms are required. Such,
so-called unified-atom force fields treat hydrogen atoms on non-polar moieties as charges
on the adjacent (typically carbon) atoms. Hydrogen atoms on polar moieties (e.g. hydroxyl
and amino groups) are treated explicitly. They are necessary for modelling hydrogen bonds
which are highly directional and cannot be modelled with a diffuse charge. The unified-
atom approach removes some degrees of freedom, speeding up calculations.
Once all necessary hydrogen atoms are in place, other structural aspects, such as wa-
ter molecules, multiple occupancies, disulfide bridges etc. need to be properly addressed.
Before the simulation, macromolecule’s geometry may be optimised.
1.3.3 Molecular Docking
Active sites are usually described in literature as having hydrophobic pockets, oxoanion
holes, hydrogen bond donors/acceptors and similar structural features (Nelson and Cox
2012). These can be inferred computationally by calculating hydrophobic indices, elec-
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trostatic potentials and so on at different points in the active site. These parameters are
calculated for every point on a grid of equally spaced points encompassing the active site.
A force field is needed for calculations on the grid. The result of this calculation, a grid with
pre-calculated binding parameters, is typically referred to as a docking grid.
Ligands can be fitted in the active site by utilizing such a docking grid. Firstly, a com-
putationally fast conformational search is used to generate ligand conformers. Secondly,
the most favourable position in the grid is calculated for every generated conformer. The
calculated position corresponds to conformer’s most favourable interaction with the active
site. Finally, one or more conformers with the smallest calculated binding Δ𝐺 are retained
and reported as the results. Often they are added to the actual active site and a geometry
optimisation is performed.
Molecular docking results consist of the (optimised) macromolecule-ligand complex and
descriptors (in the form of various components of binding Δ𝐺, e.g. hydrophobic, electro-
static, dispersive components). They are ranked using a scoring function which estimates
binding Δ𝐺. Results can be correlated with experimentally measured inhibition constants
or similar activity descriptors, enabling activity prediction for ligands which did not un-
dergo experimental testing (Friesner et al. 2004).
1.3.4 Molecular Dynamics
Simulating particle behaviour using Schrödinger’s equation is prohibitively complicated for
large systems. Sir Isaac Newton’s second law can be used instead:
d𝑉 (r)
dr
= 𝑚
d2r
d𝑡2
. (1.8)
This approximation speeds up calculations considerably for macromolecular systems.
The goal is to establish positions r of every atom as a function of time 𝑡. In effect, this
requires solving 𝑛 partial differential equations like equation 1.8 for a system of 𝑛 atoms.
Equations in this system are all interrelated since the potential energy of an atom de-
pends on positions of all other atoms, making the system impossible to solve analytically
in most cases. Numerical approach is employed instead. In this way, molecular dynamics
(MD) simulations are obtained. In one MD scheme, starting from known initial (𝑡 = 0)
positions and velocities of all atoms accelerations can be calculated using equation 1.8. In-
tegrating accelerations over a short time period Δ𝑡 yields atomic positions and velocities
at time 𝑡 + Δ𝑡. This procedure is repeated until the desired time 𝑡 is reached. The princi-
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ples outlined are only the basics. Various integration schemes exist with subtle differences
between them.
Preprocessed macromolecular structures provide some initial atomic positions. Ligands
from molecular docking may be added to the active site, or they may be manually placed.
MD simulations are used to simulate behaviour of macromolecules in water solution, so
they are immersed in a box of randomly oriented water molecules. Counterions are added
when necessary to neutralize macromolecular charge or to obtain specific ionic strength.
The geometry of the system (macromolecule, ligands, water molecules and counterions) is
then optimised before the simulation starts.
Random sampling from the Maxwell-Boltzmann distribution provides initial velocities.
They affect system’s kinetic energy, and consequently its temperature. Scaling velocities
up or down, therefore, changes the temperature. Initially, the temperature is 0 K. Scaling
velocities up by a small amount during every time step increases the temperature until a
desired value is reached. The system is then maintained at that temperature by rescaling
velocities. Velocity rescaling for water molecules and counter-ions is done independently
from velocity rescaling for the macromolecule and ligands since the solvent is much larger
than the macromolecule/complex of interest (Cramer 2004; Leach 2001).
The usual starting point for an MD simulation is the canonical (NVT) ensemble, which
assumes the number of particles, volume and temperature to be constant in the system.
System’s temperature is scaled up during this phase. Afterward, the isobaric-isothermal
(NPT) ensemble is used since most experiments take place under a reasonably constant
(atmospheric) pressure and (thermostat-controlled) temperature conditions with negligible
change in particle count. These two simulation phases are called the equilibration phases.
Once the system is reasonably well-equilibrated, the production phase begins. Isobaric-
isothermal ensemble is also used, but with fewer restraints compared to previous phases.
The longer a system is simulated, the more macromolecular behaviour is explored (Frenkel
and Smit 2002; Rapaport 2004).
1.4 Research Goals
Helicobacter pylori purine nucleoside phosphorylase (HpPNP enzyme) has not been studied
as extensively as the HsPNP enyzme or the EcPNP enzyme. It has 233 amino acids, two
short of the E. coli counterpart. Their primary sequences are largely homologous (Figure
1.7).
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The main goal of this thesis is to study the HpPNP enzyme structure-function relation-
ship with the ultimate goal of development of improved HpPNP enzyme inhibitors or even
developing new, safer therapeutics for treatment of Helicobacter pylori infections. Compu-
tational methods based on crystal structures and data obtained from kinetics measurements
were employed in pursuit of this goal.
The first part of the computational investigation involved protein and ligand structure
preparation followed by molecular docking calculations. The aim was to determine how
different ligands interact with the active site and which interactions could be important
for inhibition of catalysis. For this purpose docking calculations were performed on empty
active sites and on binary complexes with sulfate and hydrogenphosphate ions. Nucleo-
sides and their analogues were used as ligands during the docking process. The favourable
docking binding modes were then compared to literature data on nucleoside interactions
with the active site, obtained crystal structures with ligands and inhibition constants.
The goals of the second part included molecular dynamics simulations of the enzyme
and its complexes with select ligands. These were largely obtained by adding ligand bind-
ing modes obtained from molecular docking to a protein structure. Crystal structures of
semi-ternary complexes were used as well when they became available. Simulation results
were analysed to determine ligand (nucleoside and hydrogenphosphate) bindingmodes and
interactions with the active site. Ligand behaviour like conformational changes during the
course of simulations was of particular interest for the analysis.
2. Methods
Molecular docking calculations and molecular dynamics (MD) simulations were employed
to study non-covalent interactions between Helicobacter pylori purine nucleoside phospho-
rylase HpPNP subunits as well as active sites’ interactions with nucleoside and hydrogen-
phosphate ligands. Most of the calculations were based on two HpPNP crystal structures,
courtesy of dr. Zoran Štefanić. In the first structure HpPNP enzyme is co-crystallized with
glycerol (acting as a cryoprotectant), and all six subunits are in the open conformation (with
the continuous helix H8). In the second structure, two subunits are in the closed conforma-
tion (helix H8 is broken into two parts), and one of those has a sulfate and a hypoxantine
ligand bound. Both structures have a water shell around the protein.
2.1 Molecular Docking
In order to obtain structures with nucleosides in active sites, molecular docking using
Glide (Schrödinger Inc., 2017; Friesner et al. 2004, 2006; Halgren et al. 2004) was utilized.
Three-dimensional nucleoside structures were drawn in Avogadro (v. 1.1.1; Hanwell et
al. 2012) and slightly optimised using the MMFF94s force field (Halgren 1996a,b,c,d, 1999;
Halgren and Nachbar 1996) in Maestro (Schrödinger Inc., 2017). After optimisation, they
were docked in open and closed active sites of the HpPNP enzyme. For the purposes of
saving computational time, docking studies were performed on dimeric structures since it
is necessary for the existence of a functional active site.
The first step of molecular docking involved grid generation. Since only the active site
was needed, two neighbouring monomers were isolated from the two available HpPNP
hexamers. Both active sites in the first dimer were open, while one of them was closed
(containing sulfate and hypoxantine) in the second selected dimer. Dimer structures were
subsequently preprocessed using the PrepWizard tool (Schrödinger Inc. 2017; Madhavi
Sastry et al. 2013). This included: fixing common structuralmistakes, assigning bond orders,
removing waters far away from the ligand active site and slightly optimising the dimer ge-
ometry with a severe restraint on non-hydrogen atoms (a harmonic potential for deviation
from initial coordinates with the force constant of 10.467 MJ mol−1 nm−2). After this initial
protein treatment, a grid was generated for one of the two active sites in a preprocessed
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dimer.
The grid box centre was determined differently for the two chosen active sites. The
centre of geometry of two amino acid residues, Phe159 and Arg217, was used for the open
active site. Hypoxantine was present in the crystal structure of the closed active site, so its
centre of geometry was used as the grid box centre. Glide utilizes two box-shaped bound-
aries for a docking grid. During docking, the ligand centre of mass is constrained to be
inside the smaller inner boundary, while the ligand atoms have to be positioned within the
outer boundary.
Three different inner boundary sizes were used: large (1.5 x 1.5 x 1.5 nm3 for ligands up
to 2.5 nm in diameter), medium (1.0 x 1.3 x 1.3 nm3 for ligands up to 1.0 nm in diameter)
and small (1.0 x 0.7 x 1.0 nm3 for ligands up to 0.8 nm in diameter). Maximum allowed
ligand diameter determines the size of the outer boundary. Furthermore, the grids were
made for four different active sites: an open active site, a closed active site, a closed active
site with a sulfate anion and a closed active site with a hydrogenphosphate anion. The
hydrogenphosphate anion was generated in silico from the sulfate anion available from the
crystal structure.
Small organic molecules, mainly purine analogues (Figure 2.1), were subsequently do-
cked using these grids. Glide extra precision (XP) docking was used, and ribosyl ring con-
formations were sampled up to 41.84 kJ mol−1 from the original minimum. Up to 10 most
favourable binding modes found were reported for each ligand, and per-residue interac-
tions were computed for all amino acids within 0.6 nm of the ligand. Root mean square
deviation (RMSD) value from the initial molecular conformation was also calculated.
2.2 Molecular Dynamics
2.2.1 Crystal Structure Preparation
Hydrogen atoms were added to HpPNP hexamer structures using the WHAT-IF service
(Vriend 1990). The sulfate ion from the closed active site of the second structure was con-
verted to a hydrogenphosphate ion in silico. The hydrogenphosphate ion was introduced to
all active sites in three steps using Maestro: the subunit containing hydrogenphosphate
was superimposed over a subunit in a HpPNP hexamer, hydrogenphosphate coordinates
were copied to the hexamer, and the process was repeated until all subunits contained
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Figure 2.1. Structures of ligands used for molecular docking into the HpPNP enzyme active
site.
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hydrogenphosphate. Nucleoside1 ligands were introduced in a similar manner: ligand-
containing HpPNP dimer complexes from molecular docking results were used for super-
position. The nucleosides used are shown on Figure 2.2.
Another system was prepared starting directly from a crystal structure of the HpPNP
enzyme containing formycin A in all six and hydrogenphosphate ions in three of six active
sites. This system was simulated in two replicas. Contents of all simulated hexamers are
summarized in Table 2.1.
(a) Adenosine.
(b) Formycin A. (c) MBα.
Figure 2.2. Structures of nucleotides chosen for molecular dynamics simulations.
Table 2.1. Configuration of all simulated systems.
Active sitesa
Name Open Closed Nucleosideb Hydrogenphosphatec
PNP1 A B C D E F — — —
PNP2 A D E F B C — —
PNP1+P A B C D E F — — A B C D E F
PNP2+P A D E F B C — A B C D E F
PNP1+P+A A B C D E F — adenosine A B C D E F
PNP1+A A B C D E F — adenosine —
PNP1+P+M A B C D E F — MBα A B C D E F
PNP3+P+F1 A B D F C E formycin A A C E
PNP3+P+F2 A B D F C E formycin A A C E
a Subunits with open or closed active sites.
b Nucleoside present in all active sites.
c Subunits containing hydrogenphosphate in their active site.
1Technically, ligands used in MD simulations, except hydrogenphosphate, should be referred to as nucle-
oside (adenosine) and analogues (formycin A, MBα). This phrase is cumbersome, and it should be repeated
often when discussing these ligands. Instead, nucleosides is used as a shorthand throughout the text.
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2.2.2 Solvation and Parametrisation
Parameters for ligands were derived from the general Amber force field (Wang et al. 2004)
using Antechamber (AmberTools14; Case et al. 2015). The program tleap (Amber-
Tools14) was used to add non-polar hydrogen atoms and hydrogen atoms of the ligands
for which the WHAT-IF service did not have adequate parameters and for subsequent
(solvation, charge neutralisation and parametrisation) steps. A cubic box of TIP3P wa-
ter molecules was generated around all preprocessed hexamers (Figure 2.3). Chloride ions
were added to neutralize the systems in terms of charge. The total volume of solvated sys-
tems is approximately 1,728 μm3, and they contain about 150 000 atoms. The protein was
parametrized using the Amber ff99SB force field.
The HpPNP amino acid residues were numbered along the primary protein sequence:
residues 1–233, 234–466, 467–699, 700–932, 933–1165, 1166–1398 belong to the A, B, C, D, E,
and F subunit, respectively. Nucleoside and hydrogenphosphate ligands were given indices
1399–1410. Their indices differ from system to system and are not in the same order as
subunits. This is a consequence of using several different tools for protein preparation.
Figure 2.3. The HpPNP enzyme surrounded by a cubic box of TIP3P water molecules.
Colours represent different subunits: A – red, B – orange, C – yellow, D – green, E – cyan,
F – blue.
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2.2.3 Minimisation and MD Simulations
Geometry optimisation of all systems was performed in five phases using pmemd.cuda
(Amber 2014; Case et al. 2015). Optimisation was terminated after one of two conditions
were met. The first condition was a limit to the number of optimization cycles: 5000 in the
first phase and 1000 in later phases. The second condition was convergence of potential en-
ergy gradient RMSD values. Potential energy difference between two minimisation cycles
𝑉𝑖+1 − 𝑉𝑖 is a reflection of global conformational influence on potential energy. Potential
energy gradient at the 𝑖-th minimisation cycle is a vector defined as:
∇𝑉𝑖 = [
𝜕𝑉
𝜕𝑥1
,
𝜕𝑉
𝜕𝑦1
,
𝜕𝑉
𝜕𝑧1
,⋯ ,
𝜕𝑉
𝜕𝑥𝑖
,
𝜕𝑉
𝜕𝑦𝑖
,
𝜕𝑉
𝜕𝑧𝑖
,⋯ ,
𝜕𝑉
𝜕𝑥𝑁
,
𝜕𝑉
𝜕𝑦𝑁
,
𝜕𝑉
𝜕𝑧𝑁 ]
𝜏
. (2.1)
As such, it emphasizes local contributions to potential energy (e.g. residue side chain
rotation, loop flexibility) which is of significant importance for proteins. The RMSD of ∇𝑉𝑖
and ∇𝑉𝑖+1 is calculated. Termination occurs when potential energy gradient RMSD falls
below 418.4 J mol−1 nm−1 for two consecutive cycles. The steepest descent algorithm was
used for the first 1000 cycles of the first and the first 100 cycles of later phases. The conjugate
gradient algorithm was used in the remaining cycles.
All protein and ligand atoms were restrained with a harmonic potential for deviation
from initial positions using a force constant of 41.84 MJ mol−1 nm−2, while all solvent atoms
were allowed to move freely and align themselves around the protein during the first op-
timisation phase. The same restraining force constant was applied to non-hydrogen atoms
in the protein in the second phase, in order to optimise hydrogen atom positions; ligand
atoms were no longer restrained as well. Only the protein backbone (Cα, C, N and O atoms)
was restrained with the same restraining force constant through the third phase, allowing
free movement of residue side chains. The fourth phase was the same as the third, but the
restraining force constant was reduced to a half, 20.92 MJ mol−1 nm−2. Finally, in the last
phase all atoms were allowed to move unrestrained.
The systemswere equilibrated using pmemd.cuda (Amber 2014) for the first phase and
mdrun (Gromacs 4.6.5; Páll et al. 2015) for the second phase. The first equilibration phase,
calculated using Amber software, lasts for 300 ps. A canonical (NVT) ensemble was used
with a time step of 1 fs. Particle mesh Ewald (PME; Essmann et al. 1995) method with 1.2 nm
cutoff was used to calculate long distance electrostatic interactions. System’s temperature
was steadily increased from 0 K to 300 K during the first 250 ps, and the temperature cou-
pling constant between HpPNP enzyme (and ligands, if any) and the bulk solvent (chloride
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ions included) was increased from 0 to 0.2 in the same time period. During the final 50 ps
the system remained at 300 K with the coupling constant slowly increasing to 1.0. Protein
atoms were restrained with a harmonic potential for deviation from initial positions using
a force constant of 13.38 MJ mol−1 nm−2. Systems’ boundaries were treated using periodic
boundary conditions.
The second equilibration phase, calculated usingGromacs, lasts 200 ps. Unlike the previ-
ous equilibration phase, this was calculated in an isobaric-isothermal (NPT) ensemble. Like
the previous phase, the time step was 1 fs, it also involved PME with a 1.2 nm cutoff for
electrostatic interactions treatment. Modified Berndsen (V-rescale) thermostat was used to
keep the temperature at 300 K, with separate rescaling for protein and bulk solvent atoms
(Bussi et al. 2007). The pressure was kept constant at 1.0 bar with a Parrinello-Rahman
barostat using isotropic scaling with 2.0 ps coupling time constant (Parrinello and Rahman
1981). No atoms were restrained during this phase. Systems’ boundaries were treated using
periodic boundary conditions.
After completing the equilibration phase, the production phase started using mdrun
(Gromacs 4.6.5). All simulations lasted for 20 ns. The time step was 1 fs in all simulations.
Temperature was kept at 300 K using a modified Berndsen thermostat, and protein atoms
were treated separately from those of bulk solvent. Pressure was kept at 1 bar using the
Parrinello-Rahman barostat. Electrostatic interactions were treated using a PME model
with a 1.2 nm cutoff. Atoms were not restrained during the production phase. Systems’
boundaries were treated using periodic boundary conditions.
2.3 Trajectory Analysis
Trajectories were analysed using tools from the Gromacs package and the mdanalysis
toolkit (v. 0.15.0; Gowers et al. 2016; Michaud-Agrawal et al. 2011) for Python 2 (Python
Software Foundation 2001). Two versions of Gromacs tools were used: 4.6.5 (Páll et al.
2015) for principal component analysis and 5.1.2 (Abraham et al. 2015) for other analyses.
Gromacs 5 tools are called from the program gmx. System visualisation was performed
using VMD software (v. 1.9.2; Humphrey et al. 1996). Open-source Pymol (DeLano 2002)
was utilized for viewing, aligning and comparing static structures at different points during
the simulation and in examination of PCA scores.
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2.3.1 Root Mean Square Deviation and Fluctuation
RMSD values were used to assess system stability over time. All systems were initially
simulated to 10 nanoseconds, but RMSD values indicated that several simulations should
be extended. Consequently, all simulations were extended to 20 ns. RMSF values were used
for determining local residue flexibility and variation thatwouldmerit further investigation.
RMSD and RMSF values were calculated using gmx rms and gmx rmsf tools from the
Gromacs 5.1.2 package.
2.3.2 Principal Component Analysis
Given the comparatively large RMSD values for most systems (Figures 3.1 and A1), princi-
pal component analysis (PCA) was performed using g_covar (Gromacs 4.6.5). Projections
of the original trajectory on the first five principal components were extracted using gmx
anaeig (Gromacs 5.1.2) and visualized using xmgrace and VMD. Structures from the be-
ginning and near the end (at 18 ns) of the production phase were obtained by gmx trj-
conv (Gromacs 5.1.2) and compared in open-source Pymol using the modevectors.py
script (Law 2012). This script displays arrows from equivalent C-α atoms of the initial to
the final structure if they are at least a certain distance apart (default cutoff: 0.4 nm; other
cutoffs were used as necessary). It was used to point out major conformational changes.
2.3.3 Semi-automated Distance and Dihedral Angle Analysis
Hexameric nature of the HpPNP enzyme made it time-consuming to explore all distances
or angles between equivalent atoms across all six subunits and in all relevant simulated
systems. Short scripts of Python code were written in Jupyter (Kluyver et al. 2016) note-
book format to automate parts of this process. They utilise existing functionality from the
mdanalysis toolkit for Python 2 for calculating distances / dihedral angles between
two/four selected atoms throughout a simulation.
The scripts were used to analyse hydrogen bonds of interest which could not be analysed
by other means (e.g. bonds between residues on the same subunit) and for quick analysis
of hydrogen bonds found during visualisation in VMD. Hydrogen–acceptor distances were
calculated in all cases. Existence and persistence of hydrogen bonds was established from
plots of hydrogen–acceptor distances versus time.
Using distance calculations, π-interactions were also determined. Special attention was
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given to the π-interactions between Phe159 and the purine or equivalent moiety of nucleo-
sides. Centroid-centroid distances of two aromatic systems were measured. The centroids
were of: six carbon atoms in Phe159’s aromatic ring, and five carbon and four nitrogen
atoms forming the five- and six-membered aromatic rings in the ligand.
Dihedral angle calculations were used to determine the nucleoside 𝜒 angles. 𝜒 is the gly-
coside bond torsional angle in normal purine nucleosides, defined as the O4′—C1—N9—C4
dihedral angle. The same atoms can be found in the analogue MBα. The equivalent angle
in formycin A is the O4′—C1—C9—C4 angle, as N9 → C9 in that analogue. Nucleoside
conformations were designated as syn if −90° ≥ 𝜒 ≥ 90° or anti if otherwise.
2.3.4 Hydrogen Bond Analysis
The mdanalysis toolkit has a module for hydrogen bond analysis (i.e. automatic de-
tection of hydrogen bonds). It searches for atom triads D—H⋯A, where all three atoms are
reasonably close, and only for donor (D) and acceptor (A) atoms on short lists of atom types.
When detecting protein-ligand hydrogen bonds, these lists are expanded to include ligand
donor and acceptor atom types.
Hydrogen bonds are determined by the H⋯A distance and the D—H⋯A angle. The
cutoff value for the latter was 120° in all analyses. The distance cutoff was varied to best
suit the analysis at hand and to reduce analysis duration if necessary.
Four hydrogen bond analyses were performed: protein-nucleoside, protein-hydrogen-
phosphate, nucleotide-hydrogenphosphate and subunit interface analysis. A copy of au-
tomation code from the previous section was modified to accommodate these analyses. All
systems and all active sites were analysed.
Protein-nucleoside hydrogen bond distance cutoff was 0.3 nm, as this allowed determi-
nation of both strong and weak hydrogen bonds that determine protein-nucleoside inter-
actions. The distance cutoff for protein-hydrogenphosphate hydrogen bonds was 0.22 nm
because hydrogenphosphate atoms are primarily coordinated by arginine side chains. The
electrostatic component of arginine-hydrogenphosphate interaction makes short contacts
between them expected. Nucleoside-hydrogenphosphate hydrogen bonds with the distance
of at most 0.25 nm were also investigated. Distance dependence over simulation time was
graphed for all bonds thus found using the matplotlib package (v. 1.5.3; Hunter 2007).
Hydrogen bonds on the protein subunit interfaces were analysed with a cutoff distance
of 0.25 nm to eliminate weak hydrogen bonds and expedite the analysis. The hydrogen
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bonds thus found were too numerous to analyse directly, so they were filtered. Bonds
which were found during less than 90% of simulation time in non-catalytic interfaces (i.e.
interfaces between subunits which do not form catalytic dimers) were filtered out. The
threshold for catalytic interfaces (i.e. interfaces between subunits which form catalytic
dimers) was lowered to 50% since fewer hydrogen bonds were detected.
3. Results
3.1 Large-scale Conformational Changes
Dynamics of large scalemotions ofHelicobacter pylori PNPwere studied using RMSD, RMSF
and principal component analysis. Graphs of RMSD over time (Figures 3.1 and A1) indicate
that it takes between 3 and 10 ns before backbone RMSD stabilizes in a system. No regularity
has been found when comparing average RMSD of different systems with respect to the
presence of ligands or ratio of open to closed active sites. In fact, two replicate systems
starting from the same crystal structure, PNP3+P+F1 and PNP3+P+F2, have significantly
different average RMSD values (0.131 nm vs 0.168 nm). In fact, PNP3+P+F2 system has the
largest average RMSD among all simulated systems, while the smallest for the PNP1+P+M
system (0.105 nm).
Although large RMSD values were noticed, visualization did not reveal any large con-
formational changes. However, only slight changes were observed, most notably in loops
(residues 157–165) pointing towards the middle of the hexamer. This change was not sys-
tematic (i.e. it was not found in all systems nor in all six subunits within any particular
system) and could not be correlated with active site conformation nor ligand presence.
PCAwas employed in an effort to find large conformational changes unobserved during
trajectory visualisation. Changes in the aforementioned 157–165 loops were found (Figures
A2–A10). These changes were absent in some systems in several, but never all six subunits.
Another large change, observed in few systems, was the movement of residues in the H8
helix (Figure A11). Breaking of the helix in two parts was observed in the PNP1+A system,
and residuemovements in an already broken helixwere observed in the PNP3+P+F2 system.
Residues in the loop just before the H8 helix were motile in the PNP2+P system. All three
observations were found on just one out of six subunits.
RMSF values for individual residues vary between 0.03 and 0.45 nm in all systems. High-
est RMSF values are near N- and C-termini (Figures 3.2 and A12) and these are the only con-
sistently repeating peaks for every subunit in all systems. Other large peaks include amino
acids that move significantly in some active sites: Arg24, Arg43, Asp204 and Arg217. The
first two arginines are involved in hydrogenphosphate binding. Asp204 accepts a hydrogen
bond from the nucleoside amino group if available, and Arg217 is often found near Asp204.
29
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Figure 3.1. Comparison of RMSD values of backbone atoms in all studied systems. Colours:
PNP1 dark green, PNP1+P orange, PNP2 cyan, PNP2+P purple, PNP1+A green, PNP1+P+A
brown, PNP1+P+M blue, PNP3+P+F1 violet, PNP3+P+F2 red.
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Figure 3.2. Comparison of per-residue RMSF values in all studied systems. Colours:
PNP1 dark green, PNP1+P orange, PNP2 cyan, PNP2+P purple, PNP1+A green, PNP1+P+A
brown, PNP1+P+M blue, PNP3+P+F1 violet, PNP3+P+F2 red.
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Table 3.1. Protein interaction with select ligands docked inside the active site.
π-interactiona Hydrogen bondb
Ligand stacking T-shape Arg217 Arg43 Thr90 Glu181 other
adenosine ± + − − − − ± − + + + + ± −
guanosine − − − − − − − + ± − + + + −
TsA + ± ± ± − ± ± − + ± − ± − −
9C − − − ± − − ± − + − − ± + +
MBα − + − − − − + − + + + − ± +
MBβ − + ± − − − + − + − ± − − +
M-58/C ± + ± − − + − − ± + ± + + +
The first symbol refers to the open, and the second to the closed active site.
+ interaction found inmost bindingmodes; ± interaction found in some bind-
ing modes; − interaction found in no binding modes.
a Interactions of nucleoside’s aromatic ring(s) with Phe159 side chain phenyl
ring.
b Hydrogen bonds involving nucleoside atoms and amino acid in question.
No regularity to these peaks has been found, except that Asp204 peaks only show up in
systems with nucleosides in all active sites. Details of interactions of these amino acids
were subsequently explored.
3.2 Interactions betweenNucleosides andAminoAcids
of the Active Site
The most common molecular docking binding modes for most ligands are near the active
site instead of within it. Large ligands tend to have better docking scores, but they dock
rarely inside the active site, particularly if a sulfate or hydrogenphosphate ion is present.
They are also never found in results obtained with the small grid which is constructed so
as to include only the active site. Ligands which fit in the small grid have poorer docking
scores in larger grids. They rarely dock outside the active site, regardless of grid size. A
summary of all protein-ligand interactions can be found in Table 3.1.
Adenosine is highly ranked in open active sites, but it almost never has one of the
top five docking scores. The ribosyl moiety of the two best binding modes (Figure 3.3)
is located away from the hydrogenphosphate active site. The other two binding modes
have the ribosyl moiety much closer to the hydrogenphosphate active site and a few more
hydrogen bonds compared with the first two modes.
Adenosine interacts with Thr90 and Glu181 in both open and closed active sites. There
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Figure 3.3. The best binding mode of adenosine in an open active site.
are π-interactions between adenosine and Phe159 in the closed active site. Hydrogen bonds
with Arg43 and His4 were found in some binding modes.
Guanosine’s binding modes are similar to the adenosine’s. Two hydrogen bonds from
the ribosyl moiety to Glu181 are common to both guanosine and adenosine. There are
significantly fewer binding modes of guanosine in the results, especially in closed active
sites. The differences between guanosine and adenosine bindingmodes are the lack ofThr90
hydrogen bond in closed sites and rarity of π-interactions with Phe159 in both closed and
open sites.
Results for the (2S,3R,4S)-2-adenosyl-3,4-dihydroxy-5-methoxytetrahydrofurane (MB)
anomers are diverse. Results contain more MBα ((2S,3R,4S,5S)-2-adenosyl-3,4-dihydro-
xy-5-methoxytetrahydrofurane) than MBβ ((2S,3R,4S,5R)-2-adenosyl-3,4-dihydroxy-5-me-
thoxytetrahydrofurane) binding modes. MBα binding modes are particularly common in
cosed active sites (Figure 3.4). MBβ usually has a higher docking score than MBα. It also
often docks to the outside of the active site. MBα andMBβ form π-interactions with Phe159
seldom in open active sites, but often in closed active sites.
The purine ring moiety in the open active site is found roughly at the same place and
in the same orientation for all binding modes of both MBα and MBβ (when docked inside
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the active site). The ribosyl moiety is sometimes oriented towards the outside of the active
site.
Nucleosides do not move significantly away from active sites. They display confor-
mational freedom despite both limited space available in the active site compared to bulk
solvent and important interactions with active site amino acids. This conformational free-
dom was evaluated by calculating the dihedral angle of the glycoside bond 𝜒 and labelling
conformers as syn or anti throughout the simulation. The syn conformation of adenosine
and formycin A is more prevalent, while the anti conformation is more frequently found for
MBα (Table 3.2). There is much variation, however: the average dihedral angle for adeno-
sine is 𝜒 = −50°±17° in the presence and 𝜒 = −80°±34° in the absence of hydrogenphosphates
in active sites. The average 𝜒 for formycin A is −2°±68°, and for MBα 𝜒 = −125°±88° (Figure
3.5).
The averaging of dihedral angles obscures sudden changes in some active sites where 𝜒
changes for as much as 240° in two steps over a span of 3 nanoseconds (figure 3.6). Plots of
𝜒 angles in all active sites are in the appendix (Figures A13–A17) Changes in the dihedral
angle do not seem to affect major hydrogen bonds between nucleosides and amino acid
residues in the active site.
Figure 3.4. The best binding mode of MBα in a HpPNP closed active site.
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Table 3.2. Nucleoside conformation with respect to the 𝜒 angle (the O4′-C1′-N9-C4 torsion angle
for adenosine and MBα, O4′-C1′-C9-C4 for formycin A) in all binding sites.
System
Binding site
A B C D E F
start end start end start end start end start end start end
PNP1+A -90° a syn anti -90° a syn syn -90° a syn anti syn anti syn
PNP1+P+A syn syn anti syn syn syn anti syn anti syn anti syn
PNP1+P+M anti anti anti anti anti anti anti anti anti anti anti anti
PNP3+P+F1 syn syn syn syn -90° a* 90° a* syn syn anti * 90° a* syn syn
PNP3+P+F2 syn syn syn syn anti * anti * syn syn anti * syn * anti syn
* Closed binding site.
bold – large conformational change (syn→anti or anti→syn) during simulation.
a Approximately between 85° and 95°.
b Approximately between −95° and −85°.
In all systems, π-interactions between nucleosides and Phe159 have been found (Fig-
ures A18–A22). The interactions are largely T-shaped. The centroid distance is somewhat
longer than expected (around 0.55 nm in most cases), and the incline angle is shallow. The
interaction is absent in some active sites, most often with formycin A.
Nucleosides form several strong and weak hydrogen bonds with the active site (Fig-
ure 3.7). Glutamate 181’s side chain accepts one or both bonds from ribosyl moiety’s 2′-
and 3′-hydroxyl groups. Hydrogen atoms connected to N6 alternate between a bond with
aspartate 204’s carboxylate (Figures A23–A27) and isoleucine 178’s carbonyl oxygen. The
H⋯A distance is less than 0.22 nm for all hydrogen bonds mentioned so far. Despite being
on opposite sides of a nucleoside (Figure 2.2), syn ↔ anti conformational changes leave
these bonds largely undisturbed.
The nitrogen N6 is bound to two hydrogen atoms. While one of them forms a strong
hydrogen bond to Asp204, the other is usually found near serine 203’s hydroxyl and some-
times also near Cys91’s carbonyl group. These bonds are considerably weaker than the one
with Asp204. Neither of these two bonds is present if the nucleoside interacts with Ile178.
Other hydrogen bonds include Arg43—H⋯O4′ usually present when hydrogenphos-
phate is bound in the active site, Gly92—H⋯N7, Thr90—H⋯N7 and N8—H⋯O==Thr90 (the
last hydrogen bond is with backbone carbonyl oxygen). Thr90 sometimes binds with N3,
but only when N6—H⋯O—Asp204 bond is present. When His4 is not doubly protonated, a
hydrogen bond between O5′ and the side chain of His4 is present. No significant hydrogen
bonds were found between a nucleoside and hydrogenphosphate.
There are three major differences between adenosine and formycin A binding modes.
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(a) Adenosine. (b) Formycin A.
(c) MBα.
Figure 3.5. Comparison of nucleosides and their respective 𝜒 angle values in binding sites.
The first is the N8—H⋯O==Thr90 hydrogen bond, which is weak and absent in some active
sites with formycin A (adenosine and MBα have C8, making them unable to form this hy-
drogen bond). Threonine 90 sometimes binds with other parts of formycin A, as mentioned
earlier; this does not happen with adenosine. The second difference is in the relative pro-
portion of N6—H⋯O—Asp204 to N6—H⋯O==Ile178 hydrogen bonds. Almost all sites with
adenosine (11/12 in two simulated systems) have the one with Asp204, whereas many with
Computational investigation of Helicobacter pylori purine nucleoside phosphorylase 36
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
Figure 3.6. 𝜒 angle in the F binding site of the PNP3+P+F1 system. Between 2 and 5 nanosec-
onds the angle changes about 240°.
formycin A (5/12 in two simulated systems) have the one with Ile178. MBα predominantly
forms bonds with Ile178 (4/6 in one simulated system). The third difference is the hydrogen
bond between O5′ and His4’s imidazole side chain which is only present in active sites with
formycin A.
3.3 Interactions betweenHydrogenphosphate Ions and
Amino Acids of the Active Site
At the beginning of production phase, the hydrogenphosphate ion is found 0.7–0.9 nm
away from the centre of mass of the closest subunit in all systems. More than half hy-
drogenphosphate ions (17/30) have a tendency to move at least 0.15 nm from their initial
position towards the exit of the active site (Table 3.3, Figures 3.8 and A28–A34). Most hy-
drogenphosphates which move out of the active site in this manner (11/17) do so during the
first 5 ns, and almost all (14/17) during 10 ns. Usually theymove 0.2–0.7 nm away from their
initial position and remain there for the rest of the simulation. They return back towards
the active site in a few instances (3/17).
All hydrogenphosphate ions do not move away from their active sites in one particular
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(a) Adenosine
(b) Adenosine
(c) Formycin A
(d) Formycin A
(e) MBα
(f) MBα
Figure 3.7. 2D and 3D representations of hydrogen bonds between nucleosides and their
binding sites. Red arrow colour in 2D representations denotes strong, and orange weak
bonds found in most binding sites. Black arrows represents bonds which are not found
very often.
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Figure 3.8. Hydrogenphosphate ions at the beginning (blue) and end (red) of simulation of
the PNP1+P system. It retained the initial position only in the C binding site (magnified
in the yellow inset). Green values next to insets represent distances between phosphorous
atoms within insets.
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system – with adenosine, the HpPNP enzyme’s natural substrate. Adenosine forms hydro-
gen bonds with the side chain of Asp204 via hydrogens attached to N6 much more readily
than formycin A or MBα. However, no temporal correlation between hydrogenphosphate’s
departure and the cleavage of the aforementioned hydrogen bond was found.
It is also worth noting that there is at least one active site in every system in which the
hydrogenphosphate does not move significantly away from its active site. Also, it does not
move away from 3 of 6 active sites with MBα. It moves away from closed as well as open
active sites.
Visualisation of hydrogenphosphate ions reveals that they frequently flip in place dur-
ing simulations. Oxygen atom positions interchange during these flips, while phosphorous
atom remains roughly at the same spot. Hydrogenphosphate RMSF values were calculated
to quantize this observation (Table A1). RMSF values are roughly 1.5–2 times higher for
hydrogenphosphates that move away from their active sites than for those who remain in
alomst all hydrogenphosphate-containing systems. There are some exceptions. Some of
the retained hydrogenphosphates have RMSF values only slightly smaller than their coun-
terparts who moved away from their active sites. RMSF values for two hydrogenphosphate
ions which move away from their active site in the PNP2+P system are slightly smaller than
the RMSF value of the onewhich remains bound. Incidentally, the two hydrogenphosphates
are found in the two closed active sites.
Arginines in the active site neutralize hydrogenphosphate’s charge. Arginine 24 and
arginine 43 from the neighbouring subunit play the largest role: they form hydrogen bonds
Table 3.3. Hydrogenphosphate ion retention
times (in ns) in different binding sites.
Name
Binding site
A B C D E F
PNP1+P 14 4.5 20 4.5 6.5 4.5
PNP2+P 20 8* 14* 3 2 3
PNP1+P+A 20 20 20 20 20 20
PNP1+P+M 20 1 20 1 20 eq.a
PNP3+P+F1 1 — 10.5* — 20* —
PNP3+P+F2 6 — 1* — 20* —
* Closed binding site.
— No hydrogenphosphate in the binding
site.
a Hydrogenphosphate left the binding site
during equilibration.
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with hydrogenphosphate ions in nearly all (28/30) active sites containing hydrogenphos-
phate at the end of all simulations. Hydrogen bonds with Arg43 largely exist (27/30) at the
beginning of the production phase; on the other hand, at the same time hydrogen bonds
with Arg24 are far less frequent (15/30). Another important arginine, Arg87, usually stays
in close contact with hydrogenphosphates in the presence of adenosine and formycin A,
but rarely with MBα or in active sites without nucleosides.
Another important amino acid which coordinates hydrogenphosphate is Thr90. The
hydrogen bond donors are both threonine’s main chain nitrogen and side chain oxygen
atoms. The most common binding mode involves both donor atoms interacting with only
one oxygen atom of hydrogenphosphate. The binding mode where donor atoms bind to
two different acceptor oxygen atoms is not so frequent. By the end of simulations usually
only one (most often oxygen) or no donor atom remains.
Other amino acids found to coordinate hydrogenphosphate ions include Gly20, Asp21,
His62, Ser203 and Arg217. Main chain nitrogen of glycine 20 often interacts with hydrogen-
phosphate at the beginning of production phase, but rarely by the end. Interactions with
His62 coincide with the presence of adenosine, while interactions with Arg217 coincide
with formycin A being present in the active site. The remaining two amino acids, Asp21
and Ser203, seldom interact with hydrogenphosphate ions.
3.4 Subunit Interfaces
There are significantly fewer hydrogen bonds between neighbouring subunits which form
catalytic dimers (i.e. on the catalytic interface) than between those which don’t (i.e. on
the non-catalytic interface; Tables A2–A10). This is most pronounced for hydrogen bonds
which show up at least 50% and 90% of simulation time.
Hydrogen bonds on the catalytic interface are listed in Table A11. The most frequent
ones are Asn44—H⋯O==Asn44 and Tyr160—H⋯O—Glu75 hydrogen bonds (Figure 3.9).
These bonds are usually reciprocal: Tyr160 from each subunit binds Glu75 from the other
one. Asparagine/asparagine bonds are more common in the presence of MBα and formycin
A, while tyrosine/glutamate ones are common in the presence of adenosine and MBα. Both
seldom exist in the absence of nucleotides. These bonds are not correlated with hydrogen-
phosphate’s exit from the active site.
The other, non-catalytic, interface has many hydrogen bonds even when considering
only the ones which occur at least 90% of simulation time (Table A12). The most com-
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Figure 3.9. Amino acids forming hydrogen bonds at the catalytic dimer interface in the
PNP1+P system.
mon three, Asp124—H⋯O==Thr111, Ser126—H⋯O—Ser110 and Arg119—H⋯O—Tyr173 are
reciprocal. The first is present ubiqutously in all systems, while the later two are absent
from some systems: Arg/Tyr bonds are almost absent in systems with formycin A, and
Ser/Ser bonds are nearly absent in adenosine-containing systems. Several other bonds, like
Thr111—H⋯O==Asp124 and Asn152—H⋯O==Ser126, also occur at least 90% of the simula-
tion time in several systems.
Visualizing the Ser126—H⋯O—Ser110 hydrogen bond revealed interesting results. The
four amino acids are close on the interface (Figure 3.10). The Ser/Ser bond is strong and
persistent (hydrogen-acceptor distance is <0.25 nm and donor-hydrogen-acceptor angle is
>120° during more than 90% of simulation time) in all systems. In most systems five or all
six bonds are present, except in the two systems with adenosine where only one bond per
system is found at least 90% of simulation time.
Two Ser/Ser bonds break in the PNP1+P+A system. Both of them can be correlated
to hydrogen bond formation between adenosine and Asp204 in one of the nearby active
sites (Figure 3.11). The pathway through which these two hydrogen bonds are connected
was found (Figure A35). It is also connected to Arg87, one of the amino acids involved in
hydrogenphosphate coordination (Figures A35 and A36).
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Figure 3.10. Select amino acids on the non-catalytic interface between the A (red with blue
labels) and F (blue with red labels) subunit in the PNP1+P+A system.
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Figure 3.11. Red – cleavage of Ser126⋯Ser110 bond. Blue – formation of adenosine⋯Asp204
bond (it breaks later because the amino group twists, and a bond with the other hydrogen
forms).
4. Discussion
4.1 Large-scale Conformational Changes
RMSD values calculated in allHpPNP enzyme simulations indicate conformational changes
which were not readily discernible during trajectory visualisation. The most pronounced
change was in the 157–165 loop. The loop was observed to be motile in several systems.
Similar changes were detected using visualisation of backbone PC1 scores (i.e. trajectory
projections on the first principal component). This could have implications in terms of nu-
cleoside binding interactions since the loop contains Phe159 which forms π-interactions
with nucleoside’s base. Loop movements could be correlated with nucleoside conforma-
tional changes.
Visualisation of backbone PCA scores also revealed splitting of the H8 helix into two.
According to literature on the EcPNP enzyme, the probable suspected of H8 helix separation
is hydrogenphosphate binding, and the active site closes as a consequence of H8 separation
(Kazazić et al. 2016; Koellner et al. 2002). The discovery of this process only in the PC1 score
of the PNP1+A system, which contains no hydrogenphoshpate ions, was unexpected. The
rarity of this finding (only one subunit out of 54 simulated in 9 systems) suggests this could
be an artefact, or the break could be an intrinsic feature of the primary protein sequence. A
more detailed examination of PCA results should precede further judgement on this matter.
4.2 InteractionsBetweenNucleotides andAminoAcids
of the Active Site
Large nucleosides dock mostly on the outer HpPNP enzyme surface near an open or closed
active site. Such binding modes probably do not contribute to HpPNP enzyme inhibition.
They usually have high docking scores, higher than small nucleosides. The probable ex-
planation is the sheer number of van der Waals contacts they form on the protein surface.
These binding modes were not investigated using MD simulations. Nucleosides of similar
size to adenosine also sometimes dock outside of the active site.
Both MD simulations and molecular docking results point to similar interactions of
43
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nucleosides with the active site. The ribosyl moiety usually makes one or two hydrogen
bonds with the side chain of Glu181. Given its placement and size, this amino acid probably
serves as an anchor for the 2′- and 3′-hydroxyl groups. The 5′-hydroxyl group interacts
with His4 from the neighbouring subunit when His4 is not protonated on both nitrogen
atoms. This was the case in molecular docking and in MD simulations with formycin A.
The ribosyl moieties of adenosine and MBα bind similarly to formycin A’s ribosyl moiety
despite of the non-existence of this bond.
Molecular docking results contain few interactions of the purine ringmoietywithHpPNP
enyzme’s active site. A common interaction is withThr90, which also interacts with hydro-
genphosphate ions. Different nucleosides have different affinity for this amino acid partly
due to their orientation in the active site. Hydrogen bonds, which are often absent from
molecular docking results, but present in molecular dynamics simulations, are the ones
with nucleoside’s N6 as the donor atom. The bond with Asp204 is sometimes present in
molecular docking results, but Ile178, Ser203, and Cys91 are not. These bonds might be
formed during ligand-induced conformational changes to the active site.
The π-interactions between nucleosides and Phe159 were sometimes found in molec-
ular docking and regularly in MD simulations. Scarcity of these interactions in molecular
docking results can probably be attributed to rigid active site treatment, like the scarcity of
N6 hydrogen bonds. This is evident from significantly more observations of π-interactions
in molecular docking results for the closed active site (Table 3.1).
The phenyl-base centroid distance during MD simulations of HpPNP enzyme is some-
what larger than expected from literature data. This is probably a consequence of several
factors. Firstly, the centroid of the whole base ring was used, rather than a particular ring,
which can slightly affect the calculated values. Secondly, the slightly larger than expected
distance might be a simulation artefact as AMBER force fields do not have explicit parame-
ters for describing π-interactions. The centroid-centroid distance over time graphs are very
similar to hydrogen-acceptor distance graphs, albeit with a larger mean value and variance.
The consistency of observation along with these qualifications lends credence to the exis-
tence of π-interaction between the base of nucleosides and Phe159’s phenyl ring during
calculated MD trajectories.
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4.3 InteractionsBetweenHydrogenphosphate Ions and
Amino Acids of the Active Site
Hydrogenphosphate ions interact mainly with Arg24, Arg43 (from the neighbouring sub-
unit), Arg87, and Thr90 of HpPNP enzyme. The nature of their interactions is largely elec-
trostatic, since arginines are positively, and hydrogenphosphate negatively charged. Inter-
actions with arginine 43 are found ubiquitously and they persist during 20 ns simulations.
Hydrogenphosphates usually interact withThr90 at the beginning, and Arg24 later on dur-
ing simulations, suggesting a potential hydrogenphosphate departure sequence.
Other residueswithwhich hydrogenphosphate ions interact includeGly20, Asp21, His62,
Ser203 and Arg217. The His62 hydrogen bonds are present in active sites with adenosine;
the Arg217 hydrogen bonds are present in active sites with formycin A. This could consti-
tute an important manner in which the nucleoside affects changes in the active site. The
interactions with other three amino acids occur sporadically across all systems.
Hydrogenphosphate ions move away from their active sites regardless of their open or
closed conformation. This is contrary to previous research on EcPNP enzyme. Hydrogen-
phosphate ions move away from the active site of that enzyme only from open active sites
with no nucleoside, and never from closed sites (Bertoša et al. 2014). Hydrogenphosphate
RMSF values could be a viable indicator of hydrogenphosphate retention in the active site
instead of active site conformation (Tables 3.3 and A1).
Hydrogenphosphates are retained in at least one active site in all simulations. This is
probably an artefact of initial crystal structures since protein subunits in them are slightly
different. The retention of hydrogenphosphate ions in all subunits of only the PNP1+P+A
system suggests a hypothetical inhibition mechanism of other nucleosides in which hy-
drogenphosphate ions are forced out of the active sites, thus preventing phosphorolysis
reaction.
4.4 Subunit Interfaces
Many more hydrogen bonds were found on non-catalytic than on catalytic interfaces, con-
trary to expectations. There are between 3 and 9 times more bonds which appear at least
50% of simulation time, depending on the simulated system. No correlation between active
site contents and the number of hydrogen bonds has been found.
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The Ser126—H⋯O—Ser110 hydrogen bonds of the non-catalytic interface were further
studied because they were rarely found in systems with adenosine. These bonds are very
near hydrogenphosphate-related residues (Figures A35 and A36). Their cleavage is also
correlated with formation of hydrogen bonds between Asp204 and adenosine. Given this
and the fact that hydrogenphosphate ions remain in their active site only in the PNP1+P+A
system, Ser/Ser bonds could be responsible for allosteric communication between adjacent
active sites.
This finding could have ramifications in terms of the reaction mechanism: hydrogen-
phosphate ions depart their active site unless nucleosides are present and engaged in cer-
tain interactions with HpPNP enzyme, possibly hydrogen bonds with Asp204. It could also
explain experimental non-persistence of hydrogenphosphate ions in the active site. Since
hydrogenphosphate ions do not move away from the active site in the PNP1+P+A system
and since there is no similar cleavage of the Ser/Ser bond in all other systems with nucle-
osides, further evidence to corroborate this claim could not be found. Future studies in-
terested in this potential allosteric pathway might focus on simulations of HpPNP enzyme
mutants (e.g. Ser126Ala, Asp204Ala, Asp204Glu) and other nucleosides (e.g. guanosine or
6-methylpurine which cannot interact with Asp204 via their carbonyl O6 atom or methyl
group, respectively).
5. Conclusions
Loops formed by residues 157–165 of the HpPNP enzyme move significantly from their
initial positions in both original trajectories and PC1 scores. Visualisation of PCA scores
also revealed separation of the H8 helix into two helices in one system. There were no
hydrogenphosphate ions in that particular system.
Large nucleosides rarely dock in either open or closed active sites, but they have high
docking scores as a consequence of the many van der Waals contacts they can make with
the outer protein surface. Even nucleosides of the similar size to natural substrates are
sometimes docked outside the active site. Molecular dynamics and molecular docking both
predict similar interactions of nucleosides with the active site. The hydrogen bonds of
the ribosyl moiety’s hydroxyl groups are usually accepted by Glu181 and His4. The base
interacts most frequently with Thr90, Asp204 and Ile178; π-interactions are formed with
Phe159. Few differences were found between binding modes of studied nucleosides, and
none with regard to openness of the active sites.
Hydrogenphosphate ions principally interact with Arg24, Arg43 (from the neighbour-
ing subunit), His62, Arg87, Thr90 (with which nucleosides interact as well), and Ser203.
Interactions with Arg24, Arg43 and Thr90 are present in all systems, while the presence
of other interactions is dependent on the existence and identity of the nucleoside in the
active site. The departure of hydrogenphosphate ions from the active site is not affected
by its openness, but it might be affected by the sort of nucleoside that is bound in the ac-
tive site since the hydrogenphosphate exit did not appear only during the simulations with
adenosine present in the active site.
Hydrogen bonds are up to 9 times more common on the non-catalytic than on the cat-
alytic interface of HpPNP enzyme. The Ser126—H⋯O—Ser110 hydrogen bonds seem to be
correlated with changes in nucleoside-Asp204 interactions and they are very near hydro-
genphosphate-related residues.
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A. Appendix
A.1 Large-scale Conformational Changes
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Figure A1. RMSD values of backbone atoms in all studied systems. Colours: PNP1 dark
green, PNP1+P orange, PNP2 cyan, PNP2+P purple, PNP1+A green, PNP1+P+A brown,
PNP1+P+M blue, PNP3+P+F1 violet, PNP3+P+F2 red.
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Figure A2. PC1 score at 0 (green) and 18 ns (blue) of the PNP1 system. Red arrows point
at the largest conformational changes found between the two conformations (Cα atoms at
least 400 pm apart).
Figure A3. PC1 score at 0 (green) and 18 ns (blue) of the PNP1+P system. Red arrows point
at the largest conformational changes found between the two conformations (Cα atoms at
least 400 pm apart).
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Figure A4. PC1 score at 0 (green) and 18 ns (blue) of the PNP1+A system. Red arrows point
at the largest conformational changes found between the two conformations (Cα atoms at
least 400 pm apart).
Figure A5. PC1 score at 0 (green) and 18 ns (blue) of the PNP1+P+A system. Red ar-
rows point at the largest conformational changes found between the two conformations
(Cα atoms at least 400 pm apart).
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Figure A6. PC1 score at 0 (green) and 18 ns (blue) of the PNP1+P+M system. Red ar-
rows point at the largest conformational changes found between the two conformations
(Cα atoms at least 400 pm apart).
Figure A7. PC1 score at 0 (green) and 18 ns (blue) of the PNP2 system. Red arrows point
at the largest conformational changes found between the two conformations (Cα atoms at
least 400 pm apart).
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Figure A8. PC1 score at 0 (green) and 18 ns (blue) of the PNP2+P system. Red arrows point
at the largest conformational changes found between the two conformations (Cα atoms at
least 400 pm apart).
Figure A9. PC1 score at 0 (green) and 18 ns (blue) of the PNP3+P+F1 system. Red ar-
rows point at the largest conformational changes found between the two conformations
(Cα atoms at least 400 pm apart).
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Figure A10. PC1 score at 0 (green) and 18 ns (blue) of the PNP3+P+F2 system. Red ar-
rows point at the largest conformational changes found between the two conformations
(Cα atoms at least 400 pm apart).
Figure A11. Breaking of the H8 helix in the PNP1+A system (PC1 scores). Green: H8 helix
at 0 ns; blue: H8 helix at 18 ns.
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Figure A12. Per-residue RMSF values in all studied systems. Colours: PNP1 dark
green, PNP1+P orange, PNP2 cyan, PNP2+P purple, PNP1+A green, PNP1+P+A brown,
PNP1+P+M blue, PNP3+P+F1 violet, PNP3+P+F2 red.
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A.2 Interactions Between Nucleotides and Amino
Acids of the Active Site
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Figure A13. Adenosine 𝜒 angles in the PNP1+A system.
Computational investigation of Helicobacter pylori purine nucleoside phosphorylase xvii
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
(A) binding site A (B) binding site B
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
(C) binding site C (D) binding site D
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
(E) binding site E (F) binding site F
Figure A14. Adenosine 𝜒 angles in the PNP1+P+A system.
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Figure A15. Formycin A 𝜒 angles in the PNP3+P+F1 system.
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Figure A16. Formycin A 𝜒 angles in the PNP3+P+F2 system.
Computational investigation of Helicobacter pylori purine nucleoside phosphorylase xx
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
(A) binding site A (B) binding site B
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
(C) binding site C (D) binding site D
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
4 8 12 16 20
−180
−120
−60
0
60
120
180
𝑡 / ns
𝜒
/
°
(E) binding site E (F) binding site F
Figure A17. MBα 𝜒 angles in the PNP1+P+M system.
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Figure A18. Distance between Phe159’s phenyl moiety and adenosine purine base centroid
in the PNP1+A system.
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Figure A19. Distance between Phe159’s phenyl moiety and adenosine purine base centroid
in the PNP1+P+A system.
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Figure A20. Distance between Phe159’s phenyl moiety and formycin A purine base centroid
in the PNP3+P+F1 system.
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Figure A21. Distance between Phe159’s phenyl moiety and formycin A purine base centroid
in the PNP3+P+F2 system.
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Figure A22. Distance between Phe159’s phenyl moiety and MBα purine base centroid in
the PNP1+P+M system.
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Figure A23. Distance between Asp204’s carboxylate oxygen and adenosine nitrogen N6 in
the PNP1+A system.
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Figure A24. Distance between Asp204’s carboxylate oxygen and adenosine nitrogen N6 in
the PNP1+P+A system.
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Figure A25. Distance between Asp204’s carboxylate oxygen and formycin A nitrogen N6
in the PNP3+P+F1 system.
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Figure A26. Distance between Asp204’s carboxylate oxygen and formycin A nitrogen N6
in the PNP3+P+F2 system.
Computational investigation of Helicobacter pylori purine nucleoside phosphorylase xxx
4 8 12 16 20
0
0.2
0.4
0.6
0.8
1
1.2
𝑡 / ns
𝑑
/
n
m
4 8 12 16 20
0
0.2
0.4
0.6
0.8
1
1.2
𝑡 / ns
𝑑
/
n
m
(A) binding site A (B) binding site B
4 8 12 16 20
0
0.2
0.4
0.6
0.8
1
1.2
𝑡 / ns
𝑑
/
n
m
4 8 12 16 20
0
0.2
0.4
0.6
0.8
1
1.2
𝑡 / ns
𝑑
/
n
m
(C) binding site C (D) binding site D
4 8 12 16 20
0
0.2
0.4
0.6
0.8
1
1.2
𝑡 / ns
𝑑
/
n
m
4 8 12 16 20
0
0.2
0.4
0.6
0.8
1
1.2
𝑡 / ns
𝑑
/
n
m
(E) binding site E (F) binding site F
Figure A27. Distance between Asp204’s carboxylate oxygen and MBα nitrogen N6 in the
PNP1+P+M system.
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A.3 Interactions Between Hydrogenphosphate Ions
and Amino Acids of the Active Site
Table A1. RMSF values (in nm) of hydrogenphosphate ions from various binding sites.
Name
Binding site
A B C D E F
PNP1+P 0.2668 0.2627 0.1345 0.2871 0.1813 0.2078
PNP2+P 0.1832 0.1707* 0.1113* 0.2202 0.2083 0.2001
PNP1+P+A 0.0465 0.0543 0.0551 0.0477 0.0953 0.0461
PNP1+P+M 0.1070 0.1604 0.0835 0.2104 0.0591 0.1844
PNP3+P+F1 0.1801 — 0.1273* — 0.1214* —
PNP3+P+F2 0.1339 — 0.1335* — 0.0822* —
* Closed binding site.
— No hydrogenphosphate in the binding site.
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(a) PNP1+P (b) PNP1+P+A
(c) PNP1+P+M (d) PNP2+P
(e) PNP3+P+F1
(f) PNP3+P+F2
Figure A28. Hydrogenphosphate ions at the beginning (blue) and end (red) of simulations
in all hydrogenphosphate-containing simulated systems.
Computational investigation of Helicobacter pylori purine nucleoside phosphorylase xxxiii
4 8 12 16 20
0
0.25
0.5
0.75
1
1.25
1.5
𝑡 / ns
𝑑
/
n
m
4 8 12 16 20
0
0.25
0.5
0.75
1
1.25
1.5
𝑡 / ns
𝑑
/
n
m
(A) binding site A (B) binding site B
4 8 12 16 20
0
0.25
0.5
0.75
1
1.25
1.5
𝑡 / ns
𝑑
/
n
m
4 8 12 16 20
0
0.25
0.5
0.75
1
1.25
1.5
𝑡 / ns
𝑑
/
n
m
(C) binding site C (D) binding site D
4 8 12 16 20
0
0.25
0.5
0.75
1
1.25
1.5
𝑡 / ns
𝑑
/
n
m
4 8 12 16 20
0
0.25
0.5
0.75
1
1.25
1.5
𝑡 / ns
𝑑
/
n
m
(E) binding site E (F) binding site F
Figure A29. Hydrogenphosphate distance from subunit centres in the PNP1+P system.
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Figure A30. Hydrogenphosphate distance from subunit centres in the PNP2+P system.
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Figure A31. Hydrogenphosphate distance from subunit centres in the PNP1+P+A system.
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Figure A32. Hydrogenphosphate distance from subunit centres in the PNP3+P+F1 system.
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Figure A33. Hydrogenphosphate distance from subunit centres in the PNP3+P+F2 system.
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Figure A34. Hydrogenphosphate distance from subunit centres in the PNP1+P+M system.
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A.4 Subunit Interfaces
Table A2. Number of hydrogen bonds between protein monomers with different frequency
(percentage of simulation time) in the PNP1 system.
frequency ≥ 90% ≥ 80% ≥ 50% ≥ 10% ≥ 1% total
catalytic interface A/D 1 2 4 15 35 74
B/E 0 0 4 6 21 58
C/F 0 0 4 10 30 84
non-catalytic interface A/F 6 13 19 41 69 133
B/D 5 12 21 39 71 133
C/E 9 10 20 41 74 135
Table A3. Number of hydrogen bonds between protein monomers with different frequency
(percentage of simulation time) in the PNP1+P system.
frequency ≥ 90% ≥ 80% ≥ 50% ≥ 10% ≥ 1% total
catalytic interface A/D 2 2 3 15 27 59
B/E 0 0 2 9 22 78
C/F 2 3 5 7 20 61
non-catalytic interface A/F 6 11 21 44 71 125
B/D 7 9 16 42 72 136
C/E 10 14 21 39 72 134
Table A4. Number of hydrogen bonds between protein monomers with different frequency
(percentage of simulation time) in the PNP1+A system.
frequency ≥ 90% ≥ 80% ≥ 50% ≥ 10% ≥ 1% total
catalytic interface A/D 1 1 2 24 35 73
B/E 1 1 1 7 28 69
C/F 1 2 4 10 28 55
non-catalytic interface A/F 8 10 22 43 69 116
B/D 5 10 21 41 79 126
C/E 9 10 21 42 70 123
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Table A5. Number of hydrogen bonds between protein monomers with different frequency
(percentage of simulation time) in the PNP1+P+A system.
frequency ≥ 90% ≥ 80% ≥ 50% ≥ 10% ≥ 1% total
catalytic interface A/D 2 3 4 21 29 69
B/E 2 3 6 8 21 59
C/F 1 3 4 10 22 56
non-catalytic interface A/F 5 8 17 44 71 133
B/D 5 8 19 49 71 129
C/E 7 9 17 42 70 131
Table A6. Number of hydrogen bonds between protein monomers with different frequency
(percentage of simulation time) in the PNP1+P+M system.
frequency ≥ 90% ≥ 80% ≥ 50% ≥ 10% ≥ 1% total
catalytic interface A/D 1 4 7 11 20 54
B/E 0 1 5 12 26 58
C/F 3 3 5 9 18 46
non-catalytic interface A/F 12 14 19 37 67 110
B/D 7 10 20 43 76 132
C/E 12 17 22 40 65 116
Table A7. Number of hydrogen bonds between protein monomers with different frequency
(percentage of simulation time) in the PNP2 system.
frequency ≥ 90% ≥ 80% ≥ 50% ≥ 10% ≥ 1% total
catalytic interface A/D 1 1 2 10 25 67
B/E 0 0 3 9 23 81
C/F 0 0 3 8 22 61
non-catalytic interface A/F 4 8 21 41 67 131
B/D 9 12 24 41 69 126
C/E 9 13 21 42 68 133
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Table A8. Number of hydrogen bonds between protein monomers with different frequency
(percentage of simulation time) in the PNP2+P system.
frequency ≥ 90% ≥ 80% ≥ 50% ≥ 10% ≥ 1% total
catalytic interface A/D 1 2 4 11 26 62
B/E 1 4 6 10 23 59
C/F 1 3 4 8 27 79
non-catalytic interface A/F 5 11 19 35 70 132
B/D 8 10 18 45 73 136
C/E 9 13 18 41 71 131
Table A9. Number of hydrogen bonds between protein monomers with different frequency
(percentage of simulation time) in the PNP3+P+F1 system.
frequency ≥ 90% ≥ 80% ≥ 50% ≥ 10% ≥ 1% total
catalytic interface A/D 1 3 4 18 35 84
B/E 2 2 4 20 42 97
C/F 2 2 5 19 41 83
non-catalytic interface A/F 5 13 22 40 74 131
B/D 4 8 20 45 69 136
C/E 6 9 21 40 72 134
Table A10. Number of hydrogen bonds on protein interfaces which occur with different
frequency (percentage of simulation time) in the PNP3+P+F2 system.
frequency ≥ 90% ≥ 80% ≥ 50% ≥ 10% ≥ 1% 0.05%
catalytic interface A/D 1 1 4 16 29 77
B/E 2 2 4 21 33 71
C/F 3 4 6 16 33 79
non-catalytic interface A/F 5 8 24 51 79 143
B/D 4 9 19 48 79 131
C/E 7 9 20 41 71 127
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Table A11. Hydrogen bonds with at least 50% frequency (percentage of simulation time) on
the non-catalytic monomer-monomer interfaces. Chain symbols represent the monomer
on which hydrogen bond donor is situated; if both are present, monomers interact via two
reciprocal hydrogen bonds. Symbolsm and s after amino acid label represent main and side
chain donor/acceptor groups, respectively.
Donor Asn44s Tyr160s Arg43s Arg43s Arg43s Asn44s Lys114s Tyr160s
System Acceptor Asn44m Glu75s Gly63m Gly20m Asp21s Arg43m Asp112s Ile71m
PNP1 A/D AD A A
B/E BE BE
C/F CF CF
PNP1+P A/D AD A
B/E BE
C/F CF CF C
PNP1+A A/D AD AD
B/E BE BE E E
C/F C CF C
PNP1+P+A A/D AD AD
B/E BE BE E E
C/F CF C C
PNP1+P+M A/D AD AD D A A
B/E BE B B E
C/F CF CF C
PNP2 A/D A A
B/E B BE
C/F C CF
PNP2+P A/D A AD A
B/E BE BE E B
C/F CF CF
PNP3+P+F1 A/D AD AD
B/E BE B E
C/F CF CF F
PNP3+P+F2 A/D A
B/E BE
C/F CF F F C
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FigureA35. Amino acids between the Ser110/Ser126 bond on theA/F non-catalytic interface
and: hydrogenphosphate (Ser110 – Ser155 –Glu179 –Arg87 – PO4); adenosine N6 (Ser110 –
Ser155 – Glu179 – Ile 178 – Gly92 – Ala93 – Asp204 – N6) in the F subunit of the PNP1+P+A
system.
Figure A36. Amino acids in the A subunit between hydrogenphosphate and the
Ser110/Ser126 bond on the A/F non-catalytic interface in the PNP1+P+A system.
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